» Articles » PMID: 31832973

Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis

Overview
Journal Mol Neurobiol
Date 2019 Dec 14
PMID 31832973
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Gallic acid (3,4,5-trihydroxybenzoic acid, GA), a phenolic acid, is ubiquitous in almost all parts of the plant. In the present study, a neuroinflammatory rat model using intranigral infusion of lipopolysaccharides (LPS, 4 μg/μL) was employed to study the neuroprotective effect of GA which was orally administered daily. Compared with the vehicle-treated rats, systemic administration of GA (100 mg/kg) significantly attenuated LPS-induced increases in glial fibrillary acidic protein (a biomarker of activated astrocytes) and ED-1 (a biomarker of activated microglia), as well as inducible nitric oxide synthase (iNOS, a proinflammatory enzyme) and interleukin-1β (a proinflammatory cytokine), in the LPS-infused substantia nigra (SN) of rat brain. At the same time, GA attenuated LPS-induced elevation in heme oxygenase-1 level (a redox-regulated protein) and α-synuclein aggregation (a hallmark of CNS neurodegeneration), suggesting that GA is capable of inhibiting LPS-induced oxidative stress and protein conjugation. Furthermore, GA prevented LPS-induced caspase 3 activation (a biomarker of programmed cell death) and LPS-induced increases in receptor-interacting protein kinase (RIPK)-1 and RIPK-3 levels (biomarkers of necroptosis), indicating that GA inhibited LPS-induced apoptosis and necroptosis in the nigrostriatal dopaminergic system of rat brain. Moreover, an in vitro study was employed to investigate the anti-inflammatory effect of GA on BV2 microglial cells which were subjected to LPS (1 μg/mL) treatment. Consistently, co-incubation of GA diminished LPS-induced increases in iNOS mRNA and iNOS protein expression in the treated BV-2 cells as well as NO production in the culture medium. The anti-oxidative activity of GA was evaluated using iron-induced lipid peroxidation of brain homogenates. After 3-h incubation at 37 °C, GA was more potent than glutathione and less potent than trolox in inhibiting iron-induced lipid peroxidation. Conclusively, the present study suggests that GA is anti-inflammatory via attenuating LPS-induced neuroinflammation, oxidative stress, and protein conjugation. Furthermore, GA prevented LPS-induced programmed cell deaths of nigrostriatal dopaminergic neurons of the rat brain, suggesting that GA may be neuroprotective by attenuating neuroinflammation in CNS neurodegenerative diseases.

Citing Articles

Gallic acid attenuates lipopolysaccharide - induced memory deficits, neurochemical changes, and peripheral alterations in purinergic signaling.

Recart V, Spohr L, de Aguiar M, de Souza A, Goularte K, Bona N Metab Brain Dis. 2024; 40(1):43.

PMID: 39601942 DOI: 10.1007/s11011-024-01424-6.


Gallic acid ameliorates LPS-induced memory decline by modulating NF-κB, TNF-α, and Caspase 3 gene expression and attenuating oxidative stress and neuronal loss in the rat hippocampus.

Dastan M, Rajaei Z, Sharifi M, Salehi H Metab Brain Dis. 2024; 40(1):12.

PMID: 39556267 DOI: 10.1007/s11011-024-01441-5.


In Situ Detection of Neuroinflammation using Multi-cellular 3D Neurovascular Unit-on-a-Chip.

Choi J, Choi H, Lee K Adv Funct Mater. 2024; 33(46).

PMID: 39308874 PMC: 11412436. DOI: 10.1002/adfm.202304382.


The Potential Health Benefits of Gallic Acid: Therapeutic and Food Applications.

Hadidi M, Linan-Atero R, Tarahi M, Christodoulou M, Aghababaei F Antioxidants (Basel). 2024; 13(8).

PMID: 39199245 PMC: 11352096. DOI: 10.3390/antiox13081001.


MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson's disease.

Geng L, Gao W, Saiyin H, Li Y, Zeng Y, Zhang Z Mol Neurodegener. 2023; 18(1):94.

PMID: 38041169 PMC: 10693130. DOI: 10.1186/s13024-023-00686-5.


References
1.
Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L . Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies. PLoS One. 2013; 8(1):e55375. PMC: 3561263. DOI: 10.1371/journal.pone.0055375. View

2.
Qin S, Yang C, Huang W, Du S, Mai H, Xiao J . Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia. Pharmacol Res. 2018; 133:218-235. DOI: 10.1016/j.phrs.2018.01.014. View

3.
Daglia M, Di Lorenzo A, Nabavi S, Talas Z, Nabavi S . Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!. Curr Pharm Biotechnol. 2014; 15(4):362-72. DOI: 10.2174/138920101504140825120737. View

4.
Manoharan S, Guillemin G, Abiramasundari R, Essa M, Akbar M, Akbar M . The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review. Oxid Med Cell Longev. 2017; 2016:8590578. PMC: 5223034. DOI: 10.1155/2016/8590578. View

5.
Flores-Martinez Y, Fernandez-Parrilla M, Ayala-Davila J, Reyes-Corona D, Blanco-Alvarez V, Soto-Rojas L . Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide. J Immunol Res. 2018; 2018:1838921. PMC: 5964493. DOI: 10.1155/2018/1838921. View